Company news
Imaging Biometrics Limited (LSE:IBAI) news
Imaging Biometrics Limited news releases on 6ix. Latest, Oct 1, 2026: Strengthening pipeline prominent US institutions
Press releases & updates
Strengthening pipeline prominent US institutions
October 1, 2026
Adoption of Advanced Brain Tumor Imaging Platform
September 15, 2026
US Academic Medical Centre Adopts IB Clinic
August 28, 2026
Half Yearly Report to 30 June 2026
July 29, 2026
Sub-division
July 14, 2026
Publication of Phase 1 Clinical Trial
June 9, 2026
Commercialisation, Phase II Results & Revenue Path
June 5, 2026
AGM Statement and Business Update
June 3, 2026
AMENDEMENT TO NOTICE OF ANNUAL GENERAL MEETING
May 13, 2026
NOTICE OF ANNUAL GENERAL MEETING
May 12, 2026
KIRKSTALL AWARDED BBSRC/NC3Rs GRANT: GLIOBLASTOMA
May 8, 2026
Annual Report for the Year Ended 31 December 2025
April 30, 2026
Board Appointment
February 19, 2026
Update and IB Nimble Webinar – 27 February 2026
February 11, 2026
IBAI: Strategic Direction Fueling Organic Growth
January 16, 2026
Expansion Global Distribution Agreement with GE
December 10, 2025
Release of Next-Generation IB Clinic
November 26, 2025
Board Changes
November 24, 2025
Fractional Tumor Burden Mapping Enhances GBM Trial
November 13, 2025
IB Announces Completion of Phase 1 Trial of GaM
November 10, 2025
Further Re: Purchase of interest in Kirkstall Ltd
October 16, 2025
Purchase of Kirkstall and CLN - Correction
October 14, 2025
Vivan Therapeutics and IB Announce Partnership
October 3, 2025
IB Enters Agreement with MedImageMetric
September 16, 2025
Half-year Report
August 13, 2025
Grant of Share Options
August 7, 2025
IB Announces Soft Close to Phase 1 Trial
July 21, 2025
Director/PDMR Dealing
July 9, 2025
IB Provides Update on BTD Application
June 12, 2025
Change of Name
May 27, 2025
Result of AGM
May 22, 2025
Application: FDA Breakthrough Therapy Designation
May 2, 2025
Notice of AGM
April 29, 2025
Publication of Annual Report
April 25, 2025
Promising Preliminary Results of Phase 1 Study
April 11, 2025
Placing to raise £250,000
March 18, 2025
IB Expands Distribution with Blackford
February 3, 2025
Operations Update
January 22, 2025
IB and Prism Secure First Installation
January 10, 2025
Imaging Biometrics Expands Distribution
November 20, 2024
New Patent Application and Trading Update
November 5, 2024
Holding(s) in Company
October 15, 2024
PDMR dealing and TR1 announcement
October 14, 2024
Acquisition of Interest by Braveheart
October 11, 2024
IB Opens Expanded Access Program
June 25, 2024
Clinical Trial Updates
June 14, 2024
Major East Coast Health System Chooses IB Nimble
May 23, 2024
Second FDA Rare Pediatric Disease Designation
May 20, 2024
IB Software Enhances Clinical Decision-Making
May 17, 2024
Rare Pediatric Disease Designation Granted to GaM
May 10, 2024